{"id":"intravenous-iron-carboxymaltose","safety":{"commonSideEffects":[{"rate":"5-15","effect":"Injection site reactions (pain, discoloration)"},{"rate":"5-10","effect":"Headache"},{"rate":"3-8","effect":"Nausea"},{"rate":"2-5","effect":"Dizziness"},{"rate":"10-20","effect":"Hypophosphatemia"},{"rate":"2-5","effect":"Abdominal pain"}]},"_chembl":{"chemblId":"CHEMBL2108597","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The drug consists of ferric iron bound to carboxymaltose, a carbohydrate polymer that protects the iron and facilitates its transport. Once administered intravenously, the iron is released and taken up by transferrin and ferritin, allowing rapid repletion of iron stores in patients with iron deficiency. This bypasses gastrointestinal absorption limitations and enables faster correction of iron deficiency anemia compared to oral iron supplementation.","oneSentence":"Iron carboxymaltose is a ferric iron complex that delivers iron directly into the bloodstream to replenish depleted iron stores and restore hemoglobin production.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:49:49.166Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Iron deficiency anemia in patients with chronic kidney disease"},{"name":"Iron deficiency anemia in patients with heart failure"},{"name":"Iron deficiency anemia in patients intolerant to or unresponsive to oral iron therapy"}]},"trialDetails":[{"nctId":"NCT07476859","phase":"PHASE4","title":"Effect of Intravenous Iron on Quality of Life in Older Patients With Acute Coronary Syndrome","status":"RECRUITING","sponsor":"Fundación para la Investigación del Hospital Clínico de Valencia","startDate":"2026-03-05","conditions":"Acute Coronary Syndromes (ACS), Iron Deficiencies, Elderly (People Aged 65 or More)","enrollment":538},{"nctId":"NCT07384663","phase":"PHASE1","title":"EFFICACY OF IV VERSUS ORAL IRON IN THE TREATMENT OF IRON DEFICIENCY ANEMIA DURING PREGNANCY","status":"COMPLETED","sponsor":"Dr Salaha Azam","startDate":"2025-06-01","conditions":"Iron Deficiency Anaemia in Childbirth","enrollment":112},{"nctId":"NCT07370688","phase":"PHASE4","title":"Iron Infusion in Patients Undergoing Transcatheter Aortic Valve Implantation","status":"RECRUITING","sponsor":"Erasmus Medical Center","startDate":"2024-08-12","conditions":"Aortic Valve Stenosis, Iron Deficiency, TAVI(Transcatheter Aortic Valve Implantation)","enrollment":402},{"nctId":"NCT07340450","phase":"NA","title":"Comparison of Oral vs Intravenous Iron Therapy for the Treatment of Postpartum Anemia","status":"COMPLETED","sponsor":"Shahida Islam Medical Complex","startDate":"2025-02-18","conditions":"Postpartum Anaemia","enrollment":122},{"nctId":"NCT03817957","phase":"PHASE3","title":"Postoperative i.v. Iron Substitution in Patients With Diagnosed Iron Deficiency","status":"COMPLETED","sponsor":"Prof. Dr. Frank Behrens","startDate":"2018-09-18","conditions":"Iron Deficiency Anemia","enrollment":187},{"nctId":"NCT05309499","phase":"NA","title":"An Open Study on the Efficacy of Iron Therapy Using iv Iron Relative to Oral Iron for Increasing LV Systolic Function","status":"COMPLETED","sponsor":"Kazan State Medical University","startDate":"2021-12-05","conditions":"Myocardial Infarction, Iron-deficiency","enrollment":298},{"nctId":"NCT02632760","phase":"PHASE4","title":"Intravenous Iron for Treatment of Anaemia Before Cardiac Surgery","status":"COMPLETED","sponsor":"Bayside Health","startDate":"2016-07-15","conditions":"Anaemia","enrollment":955},{"nctId":"NCT06309641","phase":"","title":"Methemoglobinemia Following Intravenous Iron Treatment","status":"COMPLETED","sponsor":"Claudia Seiler","startDate":"2024-09-02","conditions":"Methemoglobinemia, Anemia, Iron Deficiencies","enrollment":50},{"nctId":"NCT07217873","phase":"PHASE2, PHASE3","title":"IntraVenous Iron in Kids With Iron Deficiency and Scoliosis Study","status":"RECRUITING","sponsor":"Columbia University","startDate":"2025-11-21","conditions":"Scoliosis Correction, Iron Deficiency, Transfusion Blood","enrollment":120},{"nctId":"NCT06958822","phase":"","title":"Ferric Carboxymaltose Methemoglobinemia Study","status":"COMPLETED","sponsor":"Ordu University","startDate":"2025-04-14","conditions":"Methemoglobinemia, Anemia, Iron-Deficiency, Parenteral Iron Therapy","enrollment":977},{"nctId":"NCT07115121","phase":"NA","title":"Comparison of the Mean Change in Hemoglobin With Ferric Carboxymaltose and IV Iron Sucrose in Anemic Antenatal Patients","status":"COMPLETED","sponsor":"Muhammad Aamir Latif","startDate":"2025-02-02","conditions":"Anemia","enrollment":40},{"nctId":"NCT04915820","phase":"NA","title":"Iron and COVID-19 Vaccine Response","status":"COMPLETED","sponsor":"Jomo Kenyatta University of Agriculture and Technology","startDate":"2021-05-29","conditions":"Iron Deficiency Anemia, Vaccine Response Impaired, COVID-19 Vaccine","enrollment":121},{"nctId":"NCT06994065","phase":"NA","title":"Efficacy of Ferric Carboxymaltose Versus Iron Sucrose in Non-dialysis Dependent Chronic Kidney Disease Patients","status":"RECRUITING","sponsor":"Sindh Institute of Urology and Transplantation","startDate":"2025-06-02","conditions":"Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease","enrollment":128},{"nctId":"NCT06833788","phase":"PHASE4","title":"Treatment of Anaemia After Caesarean With Intravenous Versus Oral Iron and Postpartum Depression","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-09","conditions":"Postpartum Depression (PPD)","enrollment":2860},{"nctId":"NCT05759078","phase":"PHASE4","title":"Effect of INtravenous FERRic Carboxymaltose Onmortality and Cardiovascular Morbidity, and Quality of Life in Iron Deficient Patients With Recent Myocardial infarCTion","status":"RECRUITING","sponsor":"Wroclaw Medical University","startDate":"2022-09-22","conditions":"Myocardial Infarction, Acute","enrollment":1000},{"nctId":"NCT07053475","phase":"PHASE4","title":"IRONICA: IRON Repletion In Heart Failure - A Comparison of Oral and IV Approaches","status":"RECRUITING","sponsor":"Syed Hamza Mufarrih","startDate":"2025-04-02","conditions":"Heart Failure, Heart Failure With Reduced Ejection Fraction (HFrEF), Heart Failure With Preserved Ejection Fraction (HFPEF)","enrollment":250},{"nctId":"NCT03833336","phase":"PHASE3","title":"Effects of Iron Therapy in Heart Failure With Preserved Ejection Fraction and Iron Deficiency (PREFER-HF)","status":"COMPLETED","sponsor":"Institut de Recerca Biomèdica de Lleida","startDate":"2017-08-23","conditions":"Heart Failure With Normal Ejection Fraction, Ferropenic Anemia","enrollment":72},{"nctId":"NCT06895993","phase":"PHASE1","title":"Bioequivalence Study of Ferric Carboxymaltose Injection in Healthy Chinese Participants","status":"COMPLETED","sponsor":"Sichuan Huiyu Pharmaceutical Co., Ltd","startDate":"2025-04-07","conditions":"Healthy Adult","enrollment":84},{"nctId":"NCT00685815","phase":"PHASE2","title":"Intravenous Iron Metabolism in Restless Legs Syndrome","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2006-11","conditions":"Restless Legs","enrollment":12},{"nctId":"NCT06948864","phase":"","title":"Evaluate the Outcomes of Ferric Carboxymaltose in Patients With Perioperative Anemia","status":"COMPLETED","sponsor":"Hospital Universitario Infanta Cristina","startDate":"2020-01-01","conditions":"Anemia, Anemia (Iron-Loading), Perioperative Bleeding","enrollment":152},{"nctId":"NCT00740246","phase":"PHASE3","title":"Safety and Tolerability of Intravenous VIT-45 in Patients With Iron Deficiency Anemia","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2005-07","conditions":"Anemia","enrollment":594},{"nctId":"NCT05545527","phase":"","title":"Neuroimaging Ancillary Study","status":"COMPLETED","sponsor":"Thomas Jefferson University","startDate":"2023-02-21","conditions":"Iron Deficiency Anemia, Iron Deficiency Anemia of Pregnancy, Neurodevelopmental Disorder of Foetus","enrollment":184},{"nctId":"NCT04343170","phase":"NA","title":"Effect of Ultra-short-term Treatment of Patients With Iron Deficiency or Anemia Undergoing Adolescent Scoliosis Correction","status":"COMPLETED","sponsor":"Tanta University","startDate":"2023-09-01","conditions":"Ultra-short-term, Iron Deficiency Anemia, Scoliosis Idiopathic","enrollment":44},{"nctId":"NCT02826681","phase":"PHASE2","title":"Randomized, Placebo-controlled Trial of Ferric Carboxymaltose in RLS Patients With Iron-deficiency Anemia","status":"TERMINATED","sponsor":"American Regent, Inc.","startDate":"2017-07-10","conditions":"Restless Legs Syndrome (RLS)","enrollment":70},{"nctId":"NCT06911034","phase":"PHASE4","title":"Ferric Carboxymaltose Versus Iron Sucrose for Treating Anemia in Pregnant Women","status":"COMPLETED","sponsor":"CMH Multan Institute of Medical Sciences","startDate":"2024-02-01","conditions":"Iron Deficiency Anemia (IDA), Pregnancy","enrollment":60},{"nctId":"NCT06686693","phase":"PHASE4","title":"Intravenous Iron Effects on Performance at High Altitude","status":"RECRUITING","sponsor":"United States Army Research Institute of Environmental Medicine","startDate":"2022-04-15","conditions":"Hypoxia","enrollment":24},{"nctId":"NCT05060731","phase":"PHASE4","title":"Iron Supplementation in Upper Non-variceal Gastrointestinal Bleeding","status":"NOT_YET_RECRUITING","sponsor":"University of Pecs","startDate":"2025-09-01","conditions":"GastroIntestinal Bleeding, Anemia","enrollment":570},{"nctId":"NCT06080893","phase":"PHASE4","title":"The Effect of Preoperative Ferric Carboxymaltose Administration on Mortality in Geriatric Hip Fractures","status":"COMPLETED","sponsor":"Istanbul University","startDate":"2023-10-10","conditions":"Hip Fractures, Anemia, Complication,Postoperative","enrollment":209},{"nctId":"NCT06437080","phase":"NA","title":"Hypoferritinemia Without Anemia Among Reproductive Age Females","status":"ACTIVE_NOT_RECRUITING","sponsor":"Akram Medical Complex","startDate":"2022-10-10","conditions":"Hypoferritenemia Without Anemia (HWA), Iron Deficiency Without Anemia)","enrollment":1331},{"nctId":"NCT03680456","phase":"PHASE4","title":"Postoperative Replacement of Intraoperative Iron Losses","status":"COMPLETED","sponsor":"Kepler University Hospital","startDate":"2020-03-06","conditions":"Blood Loss Anemia","enrollment":134},{"nctId":"NCT03036462","phase":"PHASE4","title":"Intravenous Iron in Patients With Systolic Heart Failure and Iron Deficiency to Improve Morbidity & Mortality","status":"COMPLETED","sponsor":"Universitätsklinikum Hamburg-Eppendorf","startDate":"2017-03-07","conditions":"Systolic Heart Failure, Iron Deficiency","enrollment":1105},{"nctId":"NCT03231085","phase":"NA","title":"Comparison of the Rate of Preoperative Haemoglobin After Administration of Epoetin Alpha Associated With an Oral Medical Supplementation Versus Intravenous Before Surgery of Craniosynostosis at the Child","status":"COMPLETED","sponsor":"University Hospital, Montpellier","startDate":"2017-10-31","conditions":"Craniosynostosis","enrollment":100},{"nctId":"NCT04087993","phase":"PHASE3","title":"Polyglucoferron Compared to i.v. Ferric Carboxymaltose and Oral Iron Substitution in Preoperative Treatment of Iron Deficiency Anaemia in Patients","status":"WITHDRAWN","sponsor":"Dr. Frank Behrens","startDate":"2020-05-15","conditions":"Iron Deficiency Anemia","enrollment":""},{"nctId":"NCT03769441","phase":"PHASE3","title":"Effect of Ferric Carboxymaltose on Exercise Capacity After Kidney Transplantation","status":"COMPLETED","sponsor":"University Medical Center Groningen","startDate":"2019-08-02","conditions":"Iron-deficiency, Transplant-Related Disorder","enrollment":148},{"nctId":"NCT06350955","phase":"PHASE4","title":"IV Iron-induced Hypophosphatemia After RYGB","status":"RECRUITING","sponsor":"Lucie Favre","startDate":"2024-05-02","conditions":"Hypophosphatemia, Roux-en-Y Gastric Bypass","enrollment":94},{"nctId":"NCT06542393","phase":"PHASE2","title":"PBM as Strategy to CABG Anemic Patients Bypass Graft (CABG)","status":"RECRUITING","sponsor":"Federal University of São Paulo","startDate":"2024-06-01","conditions":"Anemia, Coronary Disease, Coronary Artery Disease","enrollment":120},{"nctId":"NCT03037931","phase":"PHASE3","title":"Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency / and Sub-Study","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2017-03-15","conditions":"Heart Failure, Iron-deficiency","enrollment":3065},{"nctId":"NCT06442111","phase":"NA","title":"The Role of Intravenous Ferritin in Optimizing Postoperative Recovery Following Pancreaticoduodenectomy","status":"NOT_YET_RECRUITING","sponsor":"Seoul St. Mary's Hospital","startDate":"2024-07-01","conditions":"Pancreaticojuodenectomy","enrollment":106},{"nctId":"NCT06434025","phase":"PHASE3","title":"IV Iron and SGLT2 Inhibitor on Ventricular Function and Myocardial Iron Content in Heart Failure With Iron Deficiency","status":"NOT_YET_RECRUITING","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2024-05-24","conditions":"Heart Failure, Systolic, Iron Deficiencies","enrollment":99},{"nctId":"NCT05358509","phase":"PHASE4","title":"Reducing Anemia in Pregnancy in India: the RAPIDIRON Trial","status":"COMPLETED","sponsor":"Thomas Jefferson University","startDate":"2021-03-15","conditions":"Iron Deficiency Anemia, Infant, Low Birth Weight, Anemia of Pregnancy","enrollment":4368},{"nctId":"NCT06080555","phase":"PHASE1","title":"Bioequivalence Study of Ferric Carboxymaltose Injection in Participants With Iron Deficiency Anaemia","status":"COMPLETED","sponsor":"Sichuan Huiyu Pharmaceutical Co., Ltd","startDate":"2023-10-09","conditions":"Iron Deficiency, Anaemia","enrollment":84},{"nctId":"NCT04653181","phase":"NA","title":"Preoperative i.v. Iron Substitution in Patients With Colon Cancer","status":"UNKNOWN","sponsor":"Helsinki University Central Hospital","startDate":"2020-10-01","conditions":"Colon Cancer","enrollment":514},{"nctId":"NCT05226169","phase":"PHASE3","title":"Efficacy and Safety oF FErric CarboxymalTose in Patients With Advanced Gastric Cancer(EFFECT-AGC)","status":"UNKNOWN","sponsor":"Asan Medical Center","startDate":"2022-04-29","conditions":"Advanced Gastric Carcinoma","enrollment":330},{"nctId":"NCT03991000","phase":"PHASE3","title":"Iron in Patients With Cardiovascular Disease","status":"TERMINATED","sponsor":"Dr. med. Mahir Karakas","startDate":"2019-02-28","conditions":"Cardiovascular Diseases, Anemia, Iron-deficiency, Acute Myocardial Infarction","enrollment":8},{"nctId":"NCT05504863","phase":"","title":"RAPIDIRON Trial Follow-up Study: RAPIDIRON-KIDS Study","status":"UNKNOWN","sponsor":"Thomas Jefferson University","startDate":"2022-10-11","conditions":"Iron Deficiency Anemia, Neurodevelopmental Abnormality, Autism Spectrum Disorder","enrollment":538},{"nctId":"NCT04976179","phase":"PHASE3","title":"Iron Infusion Into a Vein Compared to Iron Tablet Taken by Mouth for Treating Iron Deficiency Anemia in Pregnancy (IVON)","status":"COMPLETED","sponsor":"University of Lagos, Nigeria","startDate":"2021-08-09","conditions":"Iron Deficiency Anemia of Pregnancy","enrollment":1056},{"nctId":"NCT03218384","phase":"PHASE2","title":"Ferric Carboxymaltose to Improve Skeletal Muscle Metabolism in Heart Failure Patients With Functional Iron Deficiency","status":"TERMINATED","sponsor":"NYU Langone Health","startDate":"2017-09-07","conditions":"Iron-deficiency","enrollment":20},{"nctId":"NCT05187637","phase":"","title":".Patient Blood Management Program in Liver Transplantation","status":"UNKNOWN","sponsor":"Hospital Universitari de Bellvitge","startDate":"2022-03-23","conditions":"Iron Deficiency Anemia","enrollment":66},{"nctId":"NCT05708170","phase":"PHASE4","title":"Impact of Intravenous Iron on Musculoskeletal Function in Older Adults","status":"NOT_YET_RECRUITING","sponsor":"Liverpool Hope University","startDate":"2023-01","conditions":"Iron Deficiency Anemia","enrollment":100},{"nctId":"NCT04968379","phase":"PHASE2","title":"Safety, Tolerability, PK and PD of Intravenous Ferric Carboxymaltose in Infants With Iron Deficiency Anemia","status":"WITHDRAWN","sponsor":"American Regent, Inc.","startDate":"2022-07-21","conditions":"Iron Deficiency, Anaemia","enrollment":""},{"nctId":"NCT04083755","phase":"PHASE4","title":"Impact of Intravenous Iron Treatment of Preoperative Anemia in Patients With LEAD (IRONPAD)","status":"UNKNOWN","sponsor":"Biobizkaia Health Research Institute","startDate":"2019-08-15","conditions":"Anemia, Peripheral Arterial Occlusive Disease","enrollment":240},{"nctId":"NCT05581420","phase":"NA","title":"Oral Versus Intravenous Iron in IBD Patients With Anti-inflammatory Therapy.","status":"UNKNOWN","sponsor":"Leiden University Medical Center","startDate":"2022-06-02","conditions":"Inflammatory Bowel Diseases","enrollment":152},{"nctId":"NCT03632525","phase":"PHASE4","title":"Intravenous Iron in Adults With Cystic Fibrosis","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2019-02-22","conditions":"Cystic Fibrosis, Iron-deficiency","enrollment":20},{"nctId":"NCT01975272","phase":"PHASE4","title":"The Use of Iron Therapy for Patients With Anemia After Caesarean Section","status":"TERMINATED","sponsor":"Maastricht University Medical Center","startDate":"2015-03-02","conditions":"Postoperative Anaemia","enrollment":27},{"nctId":"NCT03388385","phase":"PHASE4","title":"Acute Effects of Intravenous Iron on Oxidative Stress and Endothelial Dysfunction in Non-dialysis CKD","status":"UNKNOWN","sponsor":"Carol Davila University of Medicine and Pharmacy","startDate":"2017-09-20","conditions":"Renal Anemia, Iron Toxicity, Oxidative Stress","enrollment":40},{"nctId":"NCT03541213","phase":"NA","title":"Impact of Iron Deficiency and Its Correction on Mitochondrial Metabolism of the Cardiomyocyte (MitoCardioFer)","status":"COMPLETED","sponsor":"University Hospital, Angers","startDate":"2019-01-23","conditions":"Iron-deficiency, Valvular Heart Disease","enrollment":55},{"nctId":"NCT05477498","phase":"PHASE4","title":"Iron Substitution With Ferric Carboxymaltose as Treatment Strategy for Heart Failure Patients With Preserved Ejection Fraction","status":"WITHDRAWN","sponsor":"Cantonal Hosptal, Baselland","startDate":"2021-12-01","conditions":"Heart Failure With Normal Ejection Fraction, Iron-deficiency","enrollment":""},{"nctId":"NCT02410213","phase":"PHASE2","title":"A Study to Characterize the PK and PD Profile of IV FCM in Pediatric Subjects 1-17 Years Old With IDA","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2015-02-19","conditions":"Iron Deficiency Anemia (IDA)","enrollment":35},{"nctId":"NCT02308449","phase":"NA","title":"Iron Status and Human Metabolism","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2014-10","conditions":"Iron Deficiency","enrollment":29},{"nctId":"NCT03957057","phase":"PHASE3","title":"Intravenous Iron Carboxymaltose, Isomaltoside and Oral Iron Sulphate for Postpartum Anemia","status":"COMPLETED","sponsor":"University Medical Centre Ljubljana","startDate":"2020-09-10","conditions":"Postpartum Anemia Nos, Iron-deficiency","enrollment":300},{"nctId":"NCT05429749","phase":"PHASE4","title":"Intravenous Iron Supplement to Prevent Postoperative Delirium After Hip Fracture Surgery","status":"UNKNOWN","sponsor":"Seoul National University Bundang Hospital","startDate":"2020-07-30","conditions":"Hip Fractures","enrollment":264},{"nctId":"NCT03523117","phase":"PHASE3","title":"Multicenter Randomized Active-controlled Study to Investigate Efficacy & Safety of IV FCM in Pediatric Patients With IDA","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2019-01-31","conditions":"Iron Deficiency Anemia","enrollment":79},{"nctId":"NCT01100879","phase":"PHASE4","title":"Ferric Carboxymaltose for Treatment of Anaemia of Cancer in Subjects With Multiple Myeloma Receiving Chemotherapy","status":"TERMINATED","sponsor":"Vifor Pharma","startDate":"2010-03","conditions":"Iron-Deficiency Anemia","enrollment":3},{"nctId":"NCT04269707","phase":"PHASE3","title":"Efficacy and Safety of Intravenous Ferric Carboxymaltose in Pediatric Patients With Iron Deficiency Anemia and Unsatisfactory Response Oral Iron Under Study Protocol 1VIT17044","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2019-11-19","conditions":"Iron Deficiency Anemia","enrollment":7},{"nctId":"NCT01447628","phase":"PHASE2","title":"IV Iron Replacement for Iron Deficiency in Idiopathic Pulmonary Arterial Hypertension (IPAH) Patients","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2011-03-29","conditions":"Pulmonary Arterial Hypertension, Iron Deficiency","enrollment":56},{"nctId":"NCT04862715","phase":"PHASE4","title":"The Iron and Muscle Study","status":"COMPLETED","sponsor":"King's College Hospital NHS Trust","startDate":"2019-04-26","conditions":"CKD Stage 3, CKD Stage 4, Iron-deficiency","enrollment":75},{"nctId":"NCT05114278","phase":"PHASE4","title":"Effect of Intravenous Iron Supplementation on Celiac Disease Remission (IRONCEL)","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2022-02-15","conditions":"Celiac Disease","enrollment":204},{"nctId":"NCT04246021","phase":"NA","title":"Use of Intravenous Ferric Carboxymaltose in Treatment of Anemia in Cancer Patients Undergoing Chemotherapy","status":"COMPLETED","sponsor":"King Hussein Cancer Center","startDate":"2016-06-15","conditions":"Anemia, Cancer","enrollment":84},{"nctId":"NCT00520780","phase":"PHASE3","title":"Ferinject® Assessment in Patients With Iron Deficiency and Chronic Heart Failure (FAIR-HF)","status":"COMPLETED","sponsor":"Vifor Pharma","startDate":"2007-04","conditions":"Chronic Heart Failure, Iron Deficiency, Iron Deficiency Anemia","enrollment":456},{"nctId":"NCT04631679","phase":"","title":"Investigation of the Wash-out Effect of Intravenous Iron by Cell Savers (WASH-OUT)","status":"COMPLETED","sponsor":"University Hospital Muenster","startDate":"2019-11-08","conditions":"Anemia, Anemia, Iron Deficiency, Iron Deficiency Anemia Treatment","enrollment":23},{"nctId":"NCT04912661","phase":"NA","title":"Iron and Vaccine Response","status":"COMPLETED","sponsor":"Swiss Federal Institute of Technology","startDate":"2021-05-29","conditions":"Iron Deficiency Anemia, Vaccine Preventable Disease, Vaccine Response Impaired","enrollment":121},{"nctId":"NCT03380520","phase":"PHASE4","title":"Effect of Intravenous FerRic carbOxymaltose oN Reverse Remodeling Following Cardiac Resynchronization Therapy","status":"COMPLETED","sponsor":"Hasselt University","startDate":"2017-10-01","conditions":"Heart Failure","enrollment":75},{"nctId":"NCT04974021","phase":"","title":"Iron Intravenous Therapy in Reducing the Burden of Severe Arrhythmias in Heart Failure With Reduced Ejection Fraction","status":"UNKNOWN","sponsor":"Aristotle University Of Thessaloniki","startDate":"2019-06-20","conditions":"Ferric Carboxymaltose, Heart Failure With Reduced Ejection Fraction, Arrhythmias, Cardiac","enrollment":106},{"nctId":"NCT02937454","phase":"PHASE4","title":"Study to Compare Ferric Carboxymaltose With Placebo in Patients With Acute Heart Failure and Iron Deficiency","status":"COMPLETED","sponsor":"Vifor (International) Inc.","startDate":"2017-04-03","conditions":"Iron Deficiency, Heart Failure","enrollment":1132},{"nctId":"NCT04898569","phase":"PHASE4","title":"Effect of Intravenous Ferric Carboxymaltose on Hemoglobin Response and Transfusion in Patients With Iron Deficiency Anemia After Off-Pump Coronary Artery Bypass Grafting","status":"UNKNOWN","sponsor":"Yonsei University","startDate":"2019-02-10","conditions":"Coronary Artery Disease","enrollment":100},{"nctId":"NCT01374776","phase":"PHASE4","title":"Effect Of Intravenous Iron Versus Placebo On Muscle Oxidative Capacity And Physical Performance in Premenopausal Women","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2013-02","conditions":"Non Anemic Patients With Iron Deficiency (Low Ferritin Value)","enrollment":24},{"nctId":"NCT03574311","phase":"PHASE4","title":"Preoperative Intravenous Ferric Carboxymaltose and Placebo in the Treatment of Patients Undergoing Cardiac Surgery","status":"UNKNOWN","sponsor":"Turku University Hospital","startDate":"2018-10-02","conditions":"Coronary Artery Disease, Postoperative Complications, Aortic Valve Stenosis","enrollment":210},{"nctId":"NCT04786769","phase":"PHASE4","title":"Iron Supplementation in TAVI and SAVR Patients With Iron Deficiency","status":"UNKNOWN","sponsor":"Hospital de Santa Cruz, Portugal","startDate":"2022-01","conditions":"Aortic Stenosis, Iron-deficiency","enrollment":2500},{"nctId":"NCT01513369","phase":"PHASE3","title":"Ferric Carboxymaltose in Type 2 Diabetes Mellitus (T2DM) Patients With Iron Deficiency","status":"COMPLETED","sponsor":"GWT-TUD GmbH","startDate":"2012-08","conditions":"Type 2 Diabetes Mellitus, Iron Deficiency","enrollment":152},{"nctId":"NCT04616092","phase":"PHASE4","title":"Effect of Preoperative Intravenous Ferric Carboxymaltose for Clipping Surgery","status":"UNKNOWN","sponsor":"Seoul National University Hospital","startDate":"2020-11","conditions":"Cerebral Aneurysm Unruptured, Iron Deficiency Anemia, Surgery","enrollment":130},{"nctId":"NCT02469480","phase":"PHASE2","title":"Intravenous Ferric Carboxymaltose vs. Oral Iron Substitution in Patients With Metastatic Colorectal Cancer (CRC) and Iron Deficiency Anemia: a Randomized Multicenter Treatment Optimization Study.","status":"COMPLETED","sponsor":"Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest","startDate":"2015-03","conditions":"Metastatic Colorectal Cancer","enrollment":64},{"nctId":"NCT02198495","phase":"PHASE4","title":"Comparison Study of Two Iron Compounds for Treatment of Anemia in Hemodialysis Patients","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2014-09","conditions":"Anemia of Chronic Kidney Disease","enrollment":143},{"nctId":"NCT04475887","phase":"PHASE4","title":"Treatment of Anemia With Intravenous Iron in Patients Listed for Orthotopic Liver Transplantation","status":"UNKNOWN","sponsor":"Medical University of Vienna","startDate":"2020-07-23","conditions":"Liver Transplantation, Blood Loss","enrollment":60},{"nctId":"NCT04359368","phase":"","title":"Characteristics of Patients With Hypersensitivity Reactions to Intravenous Iron Infusions","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2019-09-01","conditions":"Iron-deficiency, Hypersensitivity Reactions","enrollment":42},{"nctId":"NCT03191201","phase":"PHASE4","title":"A Double Blind Randomised Placebo-controlled Trial to Assess the Role of Iron Repletion in Glucose Homeostasis.","status":"TERMINATED","sponsor":"Prof Gérard WAEBER","startDate":"2017-06-21","conditions":"Iron-deficiency, Iron Toxicity, Glucose Metabolism Disorders (Including Diabetes Mellitus)","enrollment":32},{"nctId":"NCT04286984","phase":"","title":"Implementation of a Patient Blood Management Program in Gastric Cancer Surgery","status":"COMPLETED","sponsor":"Hospital Universitari de Bellvitge","startDate":"2014-01-01","conditions":"Gastric Cancer, Anemia, Iron Deficiency, Surgery--Complications","enrollment":1063},{"nctId":"NCT03237065","phase":"PHASE3","title":"Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose or Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia","status":"COMPLETED","sponsor":"Pharmacosmos A/S","startDate":"2017-10-30","conditions":"Iron Deficiency Anaemia, Iron Deficiency Anemia","enrollment":122},{"nctId":"NCT03508466","phase":"","title":"Mechanism of Hypersensitivity Reactions to Iron Nanomedicines","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2017-10-01","conditions":"Iron-deficiency","enrollment":42},{"nctId":"NCT03238911","phase":"PHASE3","title":"Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose vs Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia","status":"COMPLETED","sponsor":"Pharmacosmos A/S","startDate":"2017-10-24","conditions":"Iron Deficiency Anaemia, Iron Deficiency Anemia","enrollment":123},{"nctId":"NCT04187716","phase":"PHASE3","title":"Intravenous Iron Injection in Cancer Patients With Anemia","status":"UNKNOWN","sponsor":"Samsung Medical Center","startDate":"2020-02-01","conditions":"Cancer Anaemia","enrollment":341},{"nctId":"NCT04168346","phase":"PHASE4","title":"Preoperative Intravenous Iron Therapy in Patients With Gastric Cancer","status":"NOT_YET_RECRUITING","sponsor":"Helsinki University Central Hospital","startDate":"2019-11","conditions":"Gastric Cancer, Anemia, Surgery","enrollment":202},{"nctId":"NCT02544464","phase":"PHASE4","title":"Does Intraoperative Intravenous Iron Enhance Postoperative Oxygenation Profile in Total Knee Arthroplasty Surgery?","status":"COMPLETED","sponsor":"Konkuk University Medical Center","startDate":"2016-08","conditions":"Osteoarthritis","enrollment":76},{"nctId":"NCT03398681","phase":"PHASE4","title":"Changes in Myocardial Iron After Iron Administration","status":"COMPLETED","sponsor":"Fundación para la Investigación del Hospital Clínico de Valencia","startDate":"2017-05-01","conditions":"Heart Failure, Iron-deficiency","enrollment":53},{"nctId":"NCT01692418","phase":"PHASE3","title":"Preoperative Intravenous Iron to Treat Anaemia in Major Surgery","status":"COMPLETED","sponsor":"University College, London","startDate":"2014-01","conditions":"Anaemia","enrollment":487},{"nctId":"NCT03399084","phase":"PHASE1","title":"A Study Comparing Two Ferric Carboxymaltose Formulations in Patients With Iron Deficiency Anemia","status":"COMPLETED","sponsor":"Sandoz","startDate":"2017-11-29","conditions":"Iron Deficiency Anemia","enrollment":71},{"nctId":"NCT02496377","phase":"NA","title":"Cross Iron (Comparative Randomized Oral Versus Systemic IRON)","status":"COMPLETED","sponsor":"University Hospital, Montpellier","startDate":"2014-08-29","conditions":"Allogenic Transfusion, Perioperative Anaemia, Knee Arthroplasty","enrollment":100},{"nctId":"NCT02271997","phase":"PHASE4","title":"Optimizing Iron Suppletion After Roux-en-Y Gastric Bypass","status":"COMPLETED","sponsor":"Rijnstate Hospital","startDate":"2014-12-04","conditions":"Iron Deficiency","enrollment":120},{"nctId":"NCT03295851","phase":"PHASE4","title":"Preoperative Intravenous Iron Infusion to Reduce Post-surgical Complications: a Pilot Randomised Control Trial","status":"UNKNOWN","sponsor":"Singapore General Hospital","startDate":"2017-11-22","conditions":"Anemia, Major Abdominal Surgery, Pre-operative","enrollment":60},{"nctId":"NCT03707249","phase":"NA","title":"Iron Status and Cardiopulmonary Physiology","status":"COMPLETED","sponsor":"Royal Centre for Defence Medicine","startDate":"2016-01-19","conditions":"Iron-deficiency, Ventricular Function, Pulmonary Vascular Resistance Abnormality","enrollment":18},{"nctId":"NCT02979132","phase":"NA","title":"Iron Long-Term Labelling Study Switzerland","status":"UNKNOWN","sponsor":"Prof. Michael B. Zimmermann","startDate":"2017-09-01","conditions":"Iron Absorption","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":7,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"intravenous iron carboxymaltose","genericName":"intravenous iron carboxymaltose","companyName":"University of Zurich","companyId":"university-of-zurich","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Iron carboxymaltose is a ferric iron complex that delivers iron directly into the bloodstream to replenish depleted iron stores and restore hemoglobin production. Used for Iron deficiency anemia in patients with chronic kidney disease, Iron deficiency anemia in patients with heart failure, Iron deficiency anemia in patients intolerant to or unresponsive to oral iron therapy.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}